Jack Ma-Backed Wuxi Diagnostics Considering a Hong Kong IPO

(Bloomberg) — Wuxi Diagnostic Investment (Cayman) Ltd., a Shanghai-based integrated diagnostics service platform, is weighing an initial public offering in Hong Kong as soon as next year, people with knowledge of the matter said. .The Chinese firm is in discussions with potential advisers on a Hong Kong listing which could raise about $400 million, said the people, who asked not to be identified as the information is private.…

Visit the original:
ChinaPulse.com

Comments are closed.